Patent rights on COVID-19 vaccines may be waived for five years
2 years, 9 months ago

Patent rights on COVID-19 vaccines may be waived for five years

The Hindu  

Intellectual property rights held by international pharmaceutical companies on COVID-19 vaccines may be relaxed for up to five years, according to a proposal by the European Union in the backdrop of a festering two-year-old dispute at the World Trade Organisation involving India, U.S., South Africa and the EU. This reprieve will, however, not apply to COVID-19 drugs and diagnostic devices, though the EU proposes a “discussion” on this in the next six months and also rebuffs India’s original demand for a complete waiver on intellectual property restrictions on covid therapeutics. Though India, along with South Africa, was among the proponents of the original waiver in 2020, it is unclear to what extent this proposal will benefit Indian manufacturers, who have in the last year, not only entered into licensing arrangements with global pharmaceutical companies but also developed indigenous vaccines. “It should coer bother patented and products pending patent applications.The WTO Secretariat is notorious for its support of US and EU positions and consequently misleaing and inaccurate legal analyses.India shouldn’t agree to any text until it has been fully vetted and endorsed by India’s technical experts,” said the letter on 18th February.

India South Africa Indian Companies Developing Countries Vaccines Patent Hindu Countries Covid Waiver Trips Wto  waived  indian  countries  waiver  covid19  companies  rights  patent  vaccines  india  wto  waivers

History of this topic

India’s patent policies: Lifeline for HIV/AIDS treatment worldwide
3 weeks, 2 days ago

India’s patent policies: Lifeline for HIV/AIDS treatment worldwide

Hindustan Times  

A major concern during the negotiations on the Trade-Related Aspects of Intellectual Property Rights Agreement, finalised in 1994, was how it would affect access to affordable medicines for diseases like HIV/AIDS since it contained provisions for a stronger and longer patent protection regime. World AIDS Day India has since 2000 emerged as the pharmacy of the developing world due to …

Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR
6 months ago

Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR

The Hindu  

India’s first indigenously developed coronavirus vaccine, Covaxin, was a joint collaboration between the Indian Council of Medical Research and the Hyderabad-based Bharat Biotech International Limited with intellectual property rights jointly shared between the two organisations. The Minister’s statement said the ICMR would provide a “well characterised” virus strain for vaccine development, the BBIL would develop the final vaccine formulation and, …

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Navigating Legal Challenges In The Development Of The Pharmaceutical Sector In India
10 months, 4 weeks ago

Navigating Legal Challenges In The Development Of The Pharmaceutical Sector In India

ABP News  

New Delhi, January 25: India's pharmaceutical sector, a key contributor to the nation's economy, has encountered significant legal challenges influencing its growth trajectory. Balancing data exclusivity, protecting clinical trial data, and ensuring timely access to generic drugs is a delicate task crucial for fostering innovation and affordability in medicine. The pharmaceutical sector in India faces challenges beyond patents, including combating …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

How India’s Vaccine Industry Will Save Millions of Children in Africa - News18
1 year, 2 months ago

How India’s Vaccine Industry Will Save Millions of Children in Africa - News18

News 18  

On 2 October 2023, when India celebrated both Gandhi and Lal Bahadur Shastri Jayanti, there was one more reason to celebrate this year. In April 2023, almost coinciding with World Malaria Day, the West African nation Ghana approved the malaria vaccine R21, even before it was approved by the WHO. The vaccine R21 is developed at the University of Oxford …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 6 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 8 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
1 year, 10 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
1 year, 11 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

A PLI-type scheme for 'atmanirbhar' vaccine industry
2 years ago

A PLI-type scheme for 'atmanirbhar' vaccine industry

Live Mint  

The government will likely unveil a ₹2,500 crore financial assistance programme to boost domestic production of vaccine raw materials to enhance self-reliance amid a resurgence of covid cases worldwide, two officials familiar with the development said. Cement investors see Q3 with mixed feelings While India is a global leader in vaccine production, it imports key raw materials needed for manufacturing. …

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court
2 years ago

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court

Live Law  

The Government cannot be held liable to compensate for the deaths occurring due to the administration of COVID-19 vaccines, said the Central Government in an affidavit filed before the Supreme Court.Responding to a petition filed by parents of two girls who died due to the adverse effects of Covishield vaccine, the Union Government submitted that : "The vaccines in use …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Donations of vaccines, medicines during Covid-19 peak made India a partner of choice for UN: Antonio Guterres
2 years, 2 months ago

Donations of vaccines, medicines during Covid-19 peak made India a partner of choice for UN: Antonio Guterres

Firstpost  

India’s voice on the global stage and international meets can only gain in authority and credibility from a strong commitment to inclusivity and respect for human rights at home, Guterres said New Delhi: India has increased its impact on the global stage by stepping up at the height of the Covid-19 pandemic and helping nations in need with donations and …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k
2 years, 3 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint  

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 3 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

Amend the Patents Act to execute TRIPS waiver
2 years, 5 months ago

Amend the Patents Act to execute TRIPS waiver

Hindustan Times  

The recently concluded 12th ministerial meeting of the World Trade Organization saw the adoption of a decision that waives certain provisions of the Trade-Related Aspects of Intellectual Property Rights agreement to expedite the production and supply of Covid-19 vaccines. Specifically speaking about India, while the TRIPS waiver talks about a plethora of mechanisms for its implementation, amending relevant Indian laws …

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence
2 years, 5 months ago

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence

News 18  

With the UK-India week on the cusp, it becomes pertinent to discuss how the United Kingdom and India have weathered rough storms during the pandemic years to come out closer than ever. It is this three-way partnership that has now been at the helm of having already delivered over 2 billion affordable, effective vaccines which have now been administered to …

每日一词∣新冠疫苗知识产权豁免 waiver of COVID-19 vaccine patents
2 years, 6 months ago

每日一词∣新冠疫苗知识产权豁免 waiver of COVID-19 vaccine patents

China Daily  

6月12日至17日在瑞士日内瓦举行的世界贸易组织第12届部长级会议就新冠疫苗知识产权豁免达成部长决定。商务部称，在会议谈判的关键阶段，作为新冠疫苗生产和供应大国，中国主动宣布不寻求享受豁免决定所提供的灵活性，彰显了大国担当。 A major decision on the waiver of intellectual property rights for COVID-19 vaccines was made at the World Trade Organization's Ministerial Conference Twelfth Session from June 12 to 17 in Geneva, Switzerland. At a pivotal stage of MC12 negotiations, China, as a major producer and a supplier of COVID-19 vaccines, announced that it will forego the flexibility of the …

每日一词∣新冠疫苗知识产权豁免 waiver of COVID-19 vaccine patents
2 years, 6 months ago

每日一词∣新冠疫苗知识产权豁免 waiver of COVID-19 vaccine patents

China Daily  

6月12日至17日在瑞士日内瓦举行的世界贸易组织第12届部长级会议就新冠疫苗知识产权豁免达成部长决定。商务部称，在会议谈判的关键阶段，作为新冠疫苗生产和供应大国，中国主动宣布不寻求享受豁免决定所提供的灵活性，彰显了大国担当。 A major decision on the waiver of intellectual property rights for COVID-19 vaccines was made at the World Trade Organization's Ministerial Conference Twelfth Session from June 12 to 17 in Geneva, Switzerland. At a pivotal stage of MC12 negotiations, China, as a major producer and a supplier of COVID-19 vaccines, announced that it will forego the flexibility of the …

每日一词∣新冠疫苗知识产权豁免 waiver of COVID-19 vaccine patents
2 years, 6 months ago

每日一词∣新冠疫苗知识产权豁免 waiver of COVID-19 vaccine patents

China Daily  

6月12日至17日在瑞士日内瓦举行的世界贸易组织第12届部长级会议就新冠疫苗知识产权豁免达成部长决定。商务部称，在会议谈判的关键阶段，作为新冠疫苗生产和供应大国，中国主动宣布不寻求享受豁免决定所提供的灵活性，彰显了大国担当。 A major decision on the waiver of intellectual property rights for COVID-19 vaccines was made at the World Trade Organization's Ministerial Conference Twelfth Session from June 12 to 17 in Geneva, Switzerland. At a pivotal stage of MC12 negotiations, China, as a major producer and a supplier of COVID-19 vaccines, announced that it will forego the flexibility of the …

Understanding India’s stand on IPR at the WTO
2 years, 6 months ago

Understanding India’s stand on IPR at the WTO

Live Mint  

With WTO countries making progress on the patent waiver for covid vaccines last week, Mint examines how crucial it is to amend the WTO’s IPR norms in the post-pandemic world, keeping in mind the need for vaccines, therapeutics and diagnostics. The Agreement on Trade Related Aspects of Intellectual Property Rights introduced patent rules into the trading system during the 1986-94 …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 6 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

WTO Meeting: Fishing, Patent, Agriculture; Know What All Was Discussed And Outcomes
2 years, 6 months ago

WTO Meeting: Fishing, Patent, Agriculture; Know What All Was Discussed And Outcomes

News 18  

Even as the 12th ministerial conference of the World Trade Organization has concluded, Commerce and Industry Minister Piyush Goyal on Friday said India is 100 per cent satisfied with the outcome of the conference and “there is no issue for which we need to return to India with any kind of worry”. The WTO’s 164 member countries have finally signed …

Explained | The Indian patent regime and its clash with the U.S. norms
2 years, 6 months ago

Explained | The Indian patent regime and its clash with the U.S. norms

The Hindu  

The story so far: The U.S. Trade Representative said in a report released last month that India was one of the most challenging major economies as far as IP protection and enforcement is concerned. In its India section, the report highlighted a range of issues in domains ranging from copyright and piracy to trademark counterfeiting and trade secrets, saying that …

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora
2 years, 6 months ago

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora

News 18  

Not so long back, a reputed international media-house had predicted gloomily that it could take over a decade for India to vaccinate its 1.4 billion population against Covid-19. The resounding success of this drive, which has been a proactive, pre-emptive, and graded response in the management of Covid-19 has been a myth-breaker on several fronts in the public health space …

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing
2 years, 7 months ago

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing

The Hindu  

Hailing India for ramping up its COVID-19 vaccine manufacturing at the right time and for ensuring supplies to the rest of the world, leaders at the World Economic Forum on Monday said everyone else needs to follow the Indian model to ensure vaccine equity and wider inoculation. Bucher said India has been a good example and the same needs to …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla

Firstpost  

The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla New Delhi: Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that “Made in India” COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. “The …

India's drugs regulator approves phase-3 trial of covid vaccine covovax
2 years, 9 months ago

India's drugs regulator approves phase-3 trial of covid vaccine covovax

India Today  

The Drugs Controller General of India granted permission on Wednesday for conducting the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation had, on March 5, recommended permission for conducting the phase-3 clinical trial for Covovax as a booster dose …

BRICS grouping should work together to support vaccine endeavours: Health Minister
2 years, 9 months ago

BRICS grouping should work together to support vaccine endeavours: Health Minister

The Hindu  

India, having one of the world’s largest vaccine manufacturing industries that supplied vaccines to more than 150 countries and met 65-70% of the World Health Organisation’s vaccine requirements, is willing to offer its robust vaccine manufacturing industry for developing vaccines for BRICS, as well as the world,” Union Health Minister Dr. Mansukh Mandaviya said on Tuesday while launching the BRICS …

Too little, too late: The Hindu Editorial on COVID-19 vaccines and patent rights
2 years, 9 months ago

Too little, too late: The Hindu Editorial on COVID-19 vaccines and patent rights

The Hindu  

In 2020, a key question that the pandemic posed was whether nations would act in solidarity and prioritise equity for the larger good over narrow self-interest. It was amid this turmoil that India and South Africa had proposed at the WTO that all patent rights for COVID-19 vaccines, drugs and diagnostics be temporarily suspended to ensure smooth manufacture and distribution. …

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms
2 years, 9 months ago

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms

News 18  

Speaking of vaccine development, never before has India incubated companies by engaging in proactive risk financing on a scale as enormous as this. NEGVAC’s vaccination strategy was based on two components: the information coming in simultaneously from the manufacturers that vaccine availability would be limited in the first six months due to restrictions in their capacities. At the same time, …

Being ready: The Hindu Editorial on vaccination and India’s third COVID-19 wave
2 years, 9 months ago

Being ready: The Hindu Editorial on vaccination and India’s third COVID-19 wave

The Hindu  

The COVID-19 pandemic is on a discernible wane. Balram Bhargava, Director-General, ICMR, said at a press conference this week that 92% of those who died of COVID-19 since January this year were unvaccinated, and underlined that vaccines and the wide vaccination coverage had played an important role in protecting hundreds of lives. The initial scepticism regarding the vaccines not having …

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer
2 years, 9 months ago

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer

News 18  

The sanctions imposed by the United States on the Russian Direct Investment Fund, which markets Sputnik V internationally has raised concerns over the manufacturing of the Covid-19 vaccine in India, the second largest producer of the jab after Russia. RDIF is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and …

'Will Not Follow World Blindly': India May Not Expand Precautionary Covid Vaccine Doses for All Ages
2 years, 10 months ago

'Will Not Follow World Blindly': India May Not Expand Precautionary Covid Vaccine Doses for All Ages

News 18  

After a high-level meeting with the WHO on the issue of boosters, the Centre has decided to reconsider its policy regarding giving a nod to precautionary doses of Covid vaccine for all age groups. The National Technical Advisory Group on Immunisation for Covid-19 met WHO officials and said that India “will not blindly follow others” on its booster dose policy. …

‘Omicron a Self-Inflicted Wound’: Patent-Free Corbevax Can Help End Covid Pandemic, Believe Its Makers
2 years, 11 months ago

‘Omicron a Self-Inflicted Wound’: Patent-Free Corbevax Can Help End Covid Pandemic, Believe Its Makers

News 18  

“When your house is on fire, you call the fire department not lawyers,” that’s how American scientist Prof. Peter Hotez explained the importance of patent waiver for Covid-19 vaccines. Professor Hotez in an exclusive interview to CNN News-18 said he along with Dr Maria Elena Bottazzi developed Corbevax and kept patents off the table to “help lower- and middle-income countries …

India completes a year of COVID-19 vaccination drive; PM Modi salutes doctors, health workers
2 years, 11 months ago

India completes a year of COVID-19 vaccination drive; PM Modi salutes doctors, health workers

India TV News  

Highlights The vaccination drive against the novel coronavirus had begun last year on January 16 Health care and frontline workers were to first to receive the COVID-19 vaccines The govt will today issue a postal stamp to mark the completion of one year of vaccination drive In a landmark, India completed a year of COVID-19 vaccination drive on Saturday. Here's …

India achieves 150-crore COVID-19 vaccination milestone
2 years, 11 months ago

India achieves 150-crore COVID-19 vaccination milestone

Op India  

COVID-19 vaccination drive in India has reached a new milestone on 7th January 2022. Bharat Biotech’s Covaxin and Serum Institute’s Covishield were the vaccines adopted by India to roll on and carry out this vaccination drive. One billion within ten months On 21st October 2021, India’s COVID-19 vaccination coverage crossed an important milestone of the 100 crore mark. From opposition …

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield
2 years, 11 months ago

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield

Firstpost  

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country. New Delhi: Serum Institute of India CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies …

In Boost to India's Covid Fight, 2 Vaccines, Covovax & Corbevax, and 1 Anti-Viral Pill Cleared in a Single Day
2 years, 11 months ago

In Boost to India's Covid Fight, 2 Vaccines, Covovax & Corbevax, and 1 Anti-Viral Pill Cleared in a Single Day

News 18  

Expanding India’s vaccine basket, the Central Drug Authority has approved the Serum Institute of India’s COVID-19 vaccine Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation. It also had recommended granting restricted emergency use approval to the drug Molnupiravir for treatment of adult patients with COVID-19 and who have high risk of progression of …

Over 148.37 crore COVID-19 vaccine doses provided to states and UTs so far, says Centre
2 years, 11 months ago

Over 148.37 crore COVID-19 vaccine doses provided to states and UTs so far, says Centre

Firstpost  

The health ministry said more than 17.72 crores balance and unutilised coronavirus vaccine doses are still available with the states and UTs to be administered New Delhi: In the ongoing nationwide vaccination drive against COVID-19, the Centre has provided more than 148.37 crore vaccine doses to States and Union Territories so far, the Union Ministry of Health and Family Welfare …

Explained | How has India responded to SARS-CoV-2 variants?
2 years, 11 months ago

Explained | How has India responded to SARS-CoV-2 variants?

The Hindu  

The story so far : India began 2021 with the hope that cases would continue to decline as had been the trend from September 2020 and that the two vaccines would help stem the spread of COVID-19. On April 8, with daily cases close to a lakh and higher than it had ever been as per India’s official count, India …

India Supplied Over 983 Lakh Covid-19 Vaccine Doses to 94 Countries, 2 UN Entities Till Dec 15: Govt
3 years ago

India Supplied Over 983 Lakh Covid-19 Vaccine Doses to 94 Countries, 2 UN Entities Till Dec 15: Govt

News 18  

India has supplied 983.068 lakh doses of COVID-19 vaccine to 94 countries and two United Nations entities in the form of grant, commercial export or through COVAX till December 15 since the start of Vaccine Maitri programme in January, 2021, the Rajya Sabha was told on Tuesday. The country supplied COVID-19 related medical and other assistance to over 150 countries …

COVID: Over 16.42 crore vaccine doses available with states, UTs
3 years ago

COVID: Over 16.42 crore vaccine doses available with states, UTs

India TV News  

Highlights Over 141.80 cr vaccine doses have been provided to states, UTs so far through Govt of India Union govt is committed to accelerating pace, expanding scope of COVID vaccination throughout India Govt of India has been supporting states, UTs by providing them COVID vaccines free of cost Over 16.42 crore Covid vaccine doses are still available with states and …

Discover Related